Femme et Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
•To assess the potential anti-dyskinetic efficacy of multiple titrated doses of AFQ056 in Parkinson’s patients with severe L-dopa induced dyskinesias using the Abnormal Involuntary Movement Scale (AIMS). •To assess the potential anti-parkinsonian effect of multiple titrated doses of AFQ056 in combination with L-dopa in Parkinson’s patients with severe L-dopa induced dyskinesias using the Unified Parkinson’s Disease Rating Scale (UPDRS) – part III. •To assess the safety and tolerability of multiple titrated doses of AFQ056 in combination with L-dopa in Parkinson’s patients with severe L-dopa induced dyskinesias .
Critère d'inclusion
- L-dopa induced dyskinesias in Parkinson’s patients with severe motor complications